EBIT at other companies
Other financials
Where this comes from
Calculated from Cumberland Pharmaceuticals’s reported figures.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's EBIT?
- Cumberland Pharmaceuticals (CPIX) reported EBIT of -$3.13M in Q1 2026.
- How has Cumberland Pharmaceuticals's EBIT changed year-over-year?
- Cumberland Pharmaceuticals's EBIT decreased by 342.2% year-over-year, from $1.29M to -$3.13M.
- What is the long-term trend for Cumberland Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's EBIT has grown at a -22.3% compound annual growth rate (CAGR), from -$7.68M to -$2.79M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.